Joseph Konowiecki Sells 25,000 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Key Points

• Director Joseph Konowiecki sold 25,000 shares of Alignment Healthcare at an average price of $17.00, amounting to a total of $425,000, reducing his ownership by 2.17%.
• Alignment Healthcare reported a quarterly revenue of $1.02 billion, exceeding analysts' expectations and reflecting a 49% year-over-year growth.
• Recent analyst upgrades have led to varied ratings for Alignment Healthcare, with Barclays moving to an "equal weight" and KeyCorp raising to "overweight" with a target price of $21.00.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) Director Joseph Konowiecki sold 25,000 shares of the firm's stock in a transaction dated Tuesday, September 9th. The shares were sold at an average price of $17.00, for a total value of $425,000.00. Following the transaction, the director directly owned 1,127,049 shares in the company, valued at $19,159,833. This trade represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC traded down $0.03 during midday trading on Wednesday, reaching $16.45. The company had a trading volume of 4,860,124 shares, compared to its average volume of 2,946,361. Alignment Healthcare, Inc. has a one year low of $8.82 and a one year high of $21.06. The firm's fifty day moving average price is $14.27 and its 200-day moving average price is $15.47. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $960.25 million. During the same period in the previous year, the firm earned ($0.13) EPS. The business's quarterly revenue was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Analyst Ratings Changes

ALHC has been the topic of a number of research analyst reports. Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and boosted their price objective for the company from $9.00 to $13.00 in a research report on Thursday, July 31st. KeyCorp raised shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price for the company in a research report on Monday, August 25th. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Zacks Research upgraded shares of Alignment Healthcare to a "hold" rating in a research report on Friday, August 8th. Finally, Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, August 10th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $18.83.

Institutional Trading of Alignment Healthcare

Institutional investors and hedge funds have recently modified their holdings of the company. Wellington Management Group LLP boosted its holdings in Alignment Healthcare by 77.9% in the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock worth $83,683,000 after buying an additional 3,257,630 shares during the period. Millennium Management LLC lifted its position in shares of Alignment Healthcare by 588.3% in the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock valued at $38,122,000 after acquiring an additional 2,896,311 shares in the last quarter. Invesco Ltd. lifted its position in shares of Alignment Healthcare by 122.3% in the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company's stock valued at $58,387,000 after acquiring an additional 2,294,739 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of Alignment Healthcare in the fourth quarter worth about $20,087,000. Finally, Vanguard Group Inc. grew its position in shares of Alignment Healthcare by 13.2% during the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company's stock worth $206,941,000 after purchasing an additional 1,295,825 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.